|
|
Like this article? PLEASE +1 it! |
|
BIOPRENEURS BITES from California Takshila University
Written by: Ryan BaidyaArticle Overview: I have been exploring social changes,economics and to some extent global politics with respect to human health and wellness. Biopreneurs' Bites is the overview of my findings - this is going to be on-going education for me as well as some of our readers. Biopreneur Bites is a section that brings much needed information to our front table.
![]() |
Free Download - Financing Biobusiness - (California Takshila University) By Ryan Baidya |
BIOPRENEURS BITES from California Takshila University
One billion people suffer from preventable, treatable diseases around the world
********************************************************************************
-----------------------------------------------------------------------------------
Global Health Progress Joins WHO and DNDi to Call For Increased Commitments to Fighting Neglected Tropical Diseases
The worldwide pharmaceutical industry is joining the World Health Organization (WHO) and the Drugs for Neglected Diseases initiative (DNDi) in calling on the G-8 nations the importance of neglected diseases as a global health threat and a major strain on the economic viability and educational development of communities worldwide.
The newly formed Alliance urged G-8 to finance successful treatment and prevention programs, to support innovative strategies that address the challenging health gaps in developing countries, and to fund research and development to develop improved diagnostic, treatment and prevention options.
Most international attention is focused on HIV/AIDS, tuberculosis, malaria and global health security. However, neglected tropical diseases - most of which are preventable and treatable - remain major causes of death and disability worldwide. These diseases receive less funding and less attention while they decrease productivity, negatively affect quality of life and increase poverty throughout the developing world.
*********************************************************************************
India's Hepatitis B Virus Drug Market Will Grow Ten-Fold by 2012
*********************************************************************************
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the Indian hepatitis B virus drug market will grow ten-fold by 2012, from $1.7 million in 2007 to $17 million in 2012. According to the new Emerging Markets report entitled Hepatitis B Virus in India, this growth will be fueled by a growing awareness of the hepatitis B virus and the growth of individual wealth among India's urban middle and upper class.
Additionally, the report finds that the number of prevalent cases of chronic hepatitis B virus in India (30.6 million in 2007) is three times that of the United States, France, Germany, Italy, Spain, United Kingdom and Japan combined. However, both diagnosis rates and drug treatment rates in India are extremely low.
**********************************************************************************
China's Hepatitis B Virus Drug Market Will Grow to $800 Million by 2012
*****************************************************************************************
Decision Resources also finds that the Chinese hepatitis B virus drug market will more than double by 2012, from $340 million in 2007 to $800 million in 2012. Both nucleoside/nucleotide analogues (NAs) and immunomodulators will experience strong double-digit growth, contributing to a robust 18 percent annual growth of the total market.
According to the new Emerging Markets report entitled Hepatitis B Virus in China, the greatest contributor to the growth of the Chinese hepatitis B drug market is the sheer size and nature of the epidemic in China- approximately 80 million Chinese people have chronic hepatitis B. Because treatment with nucleoside/nucleotide analogues is typically long-term (in many cases, lifelong), even steady diagnosis and drug-treatment rates would generate sizable near-term growth in this market. Government-sponsored improvements to the healthcare system and increasing economic prosperity among the Chinese population have also added to this market growth.
Article Tags: biopreneur, global politics, human health, ongoing education, takshila
|
About the Author: Ryan Baidya RSS for Ryan's articles - Visit Ryan's website Dr. Ryan Baidya is an entrepreneur a business strategist and who has 12+ years of experience in biotech. He launched several biotech and high-tech businesses in Silicon Valley/USA, and Tokyo/Japan. He founded BioZak and BioZak-Infobase, and served as one of the founding management. Prior to that he was with Genprobe, , HyseQ; and GeneAsia. He serves as an advisor to Golden-Embryo, Pune/India; and KZAISoft corp., Durgapur/India. He gave numerous lectures on life sciences and bio-business topics at conferences, primarily in USA, and Japan. He authored articles, patents, and commentaries. Dr. Baidya received his MS from IIT Kanpur, PhD from the University of California, Santa Cruz and MBA from the San Jose State University, CA. Currently he teaches at California Takshila University. Click here to visit Ryan's website BIOPRENEURS BITES from California Takshila University IAMAMERICACalifornia Takshila University WHO ARE BIOPRENEURS California Takshila University Doing Business in India California Takshila University What is Obama The Politepreneurc California Takshila University |
Related Forum Posts
Share this article with your friends. Fund someone's dream.
Leave a comment below or share on the left and you'll help support entrepreneurs in Africa through our partnership with Kiva. Over $50,000 raised and counting - Please keep sharing! Learn more.
Get advice & tips from famous business
owners, new articles by entrepreneur
experts, my latest website updates, &
special sneak peaks at what's to come!
Top Ten Home-Based Businesses
Unspoken Yet Important Rules for Book Proposals
How to develop the best lateral thinking skills
Email us your ideas on how to make our
website more valuable! Thank you Sharon
from Toronto Salsa Lessons / Classes for
your suggestions to make the newsletter
look like the website and profile younger
entrepreneurs like Jennifer Lopez.



